Glycosyltransferases as marker genes for the quantitative polymerase chain reaction-based detection of circulating tumour cells from blood samples of patients with breast cancer undergoing adjuvant therapy.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecular Medicine Reports

• Publication date

  2015-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/mmr.2015.3732PMID 25955084
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Importance of altered glycoprotein-bound N- and O-glycans for epithelial-to-mesenchymal transition and adhesion of cancer cells.

  2014cited by this paper
• Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers.

  2011cited by this paper
• Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin.

  2011cited by this paper
• Abstract 2305: Role of ST3Gal1 sialyltransferase in breast cancer cells

  2011cited by this paper
• Tumour-associated carbohydrate antigens in breast cancer

  2010cited by this paper
• Glycosylation Changes in Cancer

  2009cited by this paper
• Prognostic utility of glycosyltransferase expression in breast cancer.

  2008cited by this paper
• The measurement and therapeutic implications of circulating tumour cells in breast cancer

  2005cited by this paper
• Dissecting the metastatic cascade

  2004cited by this paper
• Circulating tumour cells in breast cancer.

  2004cited by this paper
• 造血器腫瘍におけるmultiplex reverse transcription polymerase chain reaction法の有用性

  2004cited by this paper
• Prognostic value of tumoral sialyltransferase expression and circulating E-selectin concentrations in node-negative breast cancer patients.

  2003cited by this paper
• Real-time PCR technology for cancer diagnostics.

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Glycoprotein glycosylation and cancer progression.

  1999cited by this paper
• Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer.

  1998cited by this paper
• Transcriptional Regulation ofN-Acetylglucosaminyltransferase V by the srcOncogene*

  1997cited by this paper
• Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V

  1995cited by this paper
• The c-Ha-ras Oncogene Induces Increased Expression of β-Galactoside α-2,6-Sialyltransferase in Rat Fibroblast (FR3T3) Cells

  1992cited by this paper
• The c-Ha-ras oncogene induces increased expression of beta-galactoside alpha-2, 6-sialyltransferase in rat fibroblast (FR3T3) cells.

  1992cited by this paper
• Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens.

  1989cited by this paper

• Analysis of Tumor Glycosylation Characteristics and Implications for Immune Checkpoint Inhibitor’s Efficacy for Breast Cancer

  2022cites this paper
• Glycosylation as a regulator of site-specific metastasis

  2021cites this paper
• Protein glycosylation in head and neck cancers: From diagnosis to treatment.

  2020cites this paper
• Alpha2,3-sialyltransferase III knockdown sensitized ovarian cancer cells to cisplatin-induced apoptosis.

  2017cites this paper
• Polypeptide N-acetylgalactosaminyltransferase-6 expression in gastric cancer

  2017cites this paper
• Altered expression of different GalNAc‑transferases is associated with disease progression and poor prognosis in women with high-grade serous ovarian cancer.

  2017cites this paper
• Novel Somatic Copy Number Alteration Identified for Cervical Cancer in the Mexican American Population

  2016cites this paper